-
Jan 23, 2025 | 
scripps.edu | Scripps Research
Calibr-Skaggs’ long-acting injectable (LAI) platform transforms oral malaria treatment atovaquone, aiming for protection from malaria for three months. January 23, 2025 LA JOLLA, CA—The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, designed a long-acting preventative medicine for malaria (CBE161 [MMV371]) that has been administered to the first cohort of healthy volunteers in a phase 1 clinical trial.
-
Jan 22, 2025 | 
scripps.edu | Scripps Research
Insights could advance new drugs to treat the progressive, fatal disease known as transthyretin amyloidosis. January 29, 2025 LA JOLLA, CA—The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded versions of the protein form dangerous clumps in the heart and along nerves—triggering a progressive and fatal disease known as transthyretin amyloidosis (ATTR).
-
Jan 17, 2025 | 
scripps.edu | Scripps Research
Scripps Research scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus—knowledge that could lead to better vaccines. January 17, 2025 LA JOLLA, CA— Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection.
-
Jan 16, 2025 | 
jamanetwork.com | Josip Car |Eric J. Topol |Scripps Research
Advocating for a Master of Digital Health Degree The rapid integration of digital technologies, especially artificial intelligence (AI), is fundamentally transforming health care.
-
Dec 10, 2024 | 
unotv.com | Lucía Castillo |Scripps Research
Los virus de la influenza animal son distintos de los virus de la influenza estacional humana y no se transmiten fácilmente entre humanos. Sin embargo, ocasionalmente, los virus de la influenza zoonótica pueden infectar a los humanos a través del contacto directo o indirecto, asegura la Organización Mundial de la Salud (OMS).
-
Dec 5, 2024 | 
scripps.edu | Scripps Research
New findings underscore the importance of ongoing surveillance for H5N1 mutations that pose risks to public health. December 05, 2024 LA JOLLA, CA—Avian influenza viruses typically require several mutations to adapt and spread among humans, but what happens when just one change can increase the risk of becoming a pandemic virus?
-
Dec 5, 2024 | 
scripps.edu | Scripps Research
Scripps Research scientists and collaborators use an innovative set of machine-learning models to discover a record-breaking material for film capacitors, key components in many energy technologies. December 05, 2024 - Content provided by Berkeley Lab, with light edits for stylistic purposes.
-
Dec 4, 2024 | 
scripps.edu | Scripps Research
Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S. December 04, 2024 LA JOLLA, CA—Alphaviruses often cause a range of illnesses that lead to fever, rash and debilitating joint pain. While they’re historically prevalent in tropical and subtropical regions of the world where virus-transmitting mosquitos are abundant, these mosquitos are expanding to new terrain—including the U.S.—as global warming intensifies.
-
Dec 3, 2024 | 
scripps.edu | Scripps Research
Technologies developed by both teams will map the human eye-brain connectome, extend the lifespan of the revived human eye, and help regenerate and monitor the optic nerve after a whole eye transplant. December 03, 2024 LA JOLLA, CA—A team of San Diego scientists are part of a major undertaking that will bring together more than 40 scientists, doctors and industry experts hand-picked from around the country to make vision-restoring whole eye transplants a reality.
-
Nov 19, 2024 | 
scripps.edu | Scripps Research
Featured scientists represent a wide range of fields including chemistry, microbiology, immunology, neuroscience and more November 19, 2024 LA JOLLA, CA—Ten scientists at Scripps Research, an increase from last year, have been named to Clarivate’s annual Highly Cited Researchers™ list for 2024. This group represents individuals who have demonstrated significant and broad influences in their fields of study, according to the global analytics company Clarivate.
